These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 8123593)
21. Co-amplification of a novel cyclophilin-like gene (PPIE) with L-myc in small cell lung cancer cell lines. Kim JO; Nau MM; Allikian KA; Mäkelä TP; Alitalo K; Johnson BE; Kelley MJ Oncogene; 1998 Aug; 17(8):1019-26. PubMed ID: 9747881 [TBL] [Abstract][Full Text] [Related]
22. Effects of interferon-beta on Daudi cells and on small cell lung carcinoma cells which over-express the c-myc oncogene. Pape KA; Floyd-Smith G Anticancer Res; 1989; 9(6):1737-42. PubMed ID: 2560625 [TBL] [Abstract][Full Text] [Related]
23. Higher potency of N-(4-hydroxyphenyl)retinamide than all-trans-retinoic acid in induction of apoptosis in non-small cell lung cancer cell lines. Zou CP; Kurie JM; Lotan D; Zou CC; Hong WK; Lotan R Clin Cancer Res; 1998 May; 4(5):1345-55. PubMed ID: 9607596 [TBL] [Abstract][Full Text] [Related]
24. Comparison of amplified and unamplified c-myc gene structure and expression in human small cell lung carcinoma cell lines. Seifter EJ; Sausville EA; Battey J Cancer Res; 1986 Apr; 46(4 Pt 2):2050-5. PubMed ID: 3004717 [TBL] [Abstract][Full Text] [Related]
25. Transitions between lung cancer phenotypes--implications for tumor progression. Mabry M; Nelkin BD; Falco JP; Barr LF; Baylin SB Cancer Cells; 1991 Feb; 3(2):53-8. PubMed ID: 1851429 [TBL] [Abstract][Full Text] [Related]
26. Retinoblastoma protein in non-small cell lung carcinoma, cells arrested for growth by retinoic acid. Maxwell SA Anticancer Res; 1994; 14(4A):1535-40. PubMed ID: 7979182 [TBL] [Abstract][Full Text] [Related]
27. [bcl-2 expression in small cell lung cancer: a mechanism for apoptosis antagonism and immune evasion]. Zheng JM; Wang DK; Jiang HM Di Yi Jun Yi Da Xue Xue Bao; 2005 Dec; 25(12):1537-9. PubMed ID: 16361157 [TBL] [Abstract][Full Text] [Related]
28. Amplification of the c-myc oncogene in a subpopulation of human small cell lung cancer. Saksela K; Bergh J; Lehto VP; Nilsson K; Alitalo K Cancer Res; 1985 Apr; 45(4):1823-7. PubMed ID: 2983887 [TBL] [Abstract][Full Text] [Related]
29. [Relationship between drug resistance and oncogenes in lung cancer cell lines]. Tanio Y Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Dec; 30 Suppl():42-7. PubMed ID: 1339094 [TBL] [Abstract][Full Text] [Related]
30. Protein kinase C-beta 2 inhibits cycling and decreases c-myc-induced apoptosis in small cell lung cancer cells. Barr LF; Campbell SE; Baylin SB Cell Growth Differ; 1997 Apr; 8(4):381-92. PubMed ID: 9101084 [TBL] [Abstract][Full Text] [Related]
31. A combination treatment of c-myc antisense DNA with all-trans-retinoic acid inhibits cell proliferation by downregulating c-myc expression in small cell lung cancer. Akie K; Dosaka-Akita H; Murakami A; Kawakami Y Antisense Nucleic Acid Drug Dev; 2000 Aug; 10(4):243-9. PubMed ID: 10984118 [TBL] [Abstract][Full Text] [Related]
32. Combination of tumor necrosis factor alpha and interferon alpha induces apoptotic cell death through a c-myc-dependent pathway in p53 mutant H226br non-small-cell lung cancer cell line. Yasuoka Y; Naomoto Y; Yamatsuji T; Takaoka M; Kimura M; Uetsuka H; Matsubara N; Fujiwara T; Gunduz M; Tanaka N; Haisa M Exp Cell Res; 2001 Dec; 271(2):214-22. PubMed ID: 11716533 [TBL] [Abstract][Full Text] [Related]
33. Effects of c-myc oncogene modulation on differentiation of human small cell lung carcinoma cell lines. van Waardenburg RC; Meijer C; Pinto-Sietsma SJ; de Vries EG; Timens W; Mulder NM Anticancer Res; 1998; 18(1A):91-5. PubMed ID: 9568061 [TBL] [Abstract][Full Text] [Related]
34. myc family DNA amplification in tumors and tumor cell lines from patients with small-cell lung cancer. Johnson BE; Brennan JF; Ihde DC; Gazdar AF J Natl Cancer Inst Monogr; 1992; (13):39-43. PubMed ID: 1327035 [TBL] [Abstract][Full Text] [Related]
35. Coexpression pattern of c-myc associated genes in a small cell lung cancer cell line with high steady state c-myc transcription. Dooley S; Wundrack I; Blin N; Welter C Biochem Biophys Res Commun; 1995 Aug; 213(3):789-95. PubMed ID: 7654239 [TBL] [Abstract][Full Text] [Related]
36. Secretion of a latent, acid activatable cathepsin L precursor by human non-small cell lung cancer cell lines. Heidtmann HH; Salge U; Havemann K; Kirschke H; Wiederanders B Oncol Res; 1993; 5(10-11):441-51. PubMed ID: 8054705 [TBL] [Abstract][Full Text] [Related]
37. Cyclooxygenase-2 expression influences the growth of human large and small cell lung carcinoma lines in athymic mice: impact of an organoselenium compound on growth regulation. El-Bayoumy K; Rose DP; Papanikolaou N; Leszczynska J; Swamy MV; Rao CV Int J Oncol; 2002 Mar; 20(3):557-61. PubMed ID: 11836568 [TBL] [Abstract][Full Text] [Related]
38. Loss of expression of death-inducing signaling complex (DISC) components in lung cancer cell lines and the influence of MYC amplification. Shivapurkar N; Reddy J; Matta H; Sathyanarayana UG; Huang CX; Toyooka S; Minna JD; Chaudhary PM; Gazdar AF Oncogene; 2002 Dec; 21(55):8510-4. PubMed ID: 12466971 [TBL] [Abstract][Full Text] [Related]
39. Combined microarray analysis of small cell lung cancer reveals altered apoptotic balance and distinct expression signatures of MYC family gene amplification. Kim YH; Girard L; Giacomini CP; Wang P; Hernandez-Boussard T; Tibshirani R; Minna JD; Pollack JR Oncogene; 2006 Jan; 25(1):130-8. PubMed ID: 16116477 [TBL] [Abstract][Full Text] [Related]
40. The myc family of oncogenes and their presence and importance in small-cell lung carcinoma and other tumour types. Prins J; De Vries EG; Mulder NH Anticancer Res; 1993; 13(5A):1373-85. PubMed ID: 8239508 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]